ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death
For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for obesity-related cancer compared with dipeptidyl peptidase-4 (DPP-4) inhibitors, according ...
2 hours ago
0
0